Clinical Trials Directory

Trials / Unknown

UnknownNCT03634787

Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis

Status
Unknown
Phase
Study type
Observational
Enrollment
280 (estimated)
Sponsor
Vilnius University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

To investigate the role of Heat Shock Proteins in the mechanism of acute severe pancreatitis. In addition to test the potential treatment target of acute pancreatitis. All patients who present with clinical symptoms of acute pancreatitis are evaluated for the enrollment of the study.

Detailed description

All patients with acute pancreatitis are evaluated according to modified Atlanta classification acute pancreatitis severity scores. Blood serum, urine and DNA samples are collected from all patients presented on admission, after 24 hours, 48 hours, 72 hours. CT is performed in al patients to evaluate necrosis of pancreas Day 5-7 since hospital admission. If necrosis is not present follow-up is stopped.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT Scan Day 5-7Computed Tomography on Day 5-7 according to a clinical protocol.

Timeline

Start date
2017-10-20
Primary completion
2021-12-01
Completion
2021-12-30
First posted
2018-08-16
Last updated
2018-08-16

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT03634787. Inclusion in this directory is not an endorsement.